β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1
- PMID: 21635612
- PMCID: PMC3176970
- DOI: 10.1111/j.1540-8167.2011.02091.x
β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1
Abstract
Introduction: β-Blocker therapy reduces syncope and sudden death in long-QT syndrome type 1 (LQT1), but the mechanism of protection is incompletely understood. This study tested the hypothesis that β-blockade reduces QT prolongation and dispersion of repolarization, measured as the T peak-to-end interval (T(pe) ), during exercise and recovery in LQT1 patients.
Methods and results: QT and T(pe) were measured in 10 LQT1 patients (33 ± 13 years) and 35 normal subjects (32 ± 12 years) during exercise tests on and off β-blockade. In LQT1 patients, β-blockade reduced QT (391 ± 25 milliseconds vs 375 ± 26 milliseconds, P = 0.04 during exercise; 419 ± 41 milliseconds vs 391 ± 39 milliseconds, P = 0.02 during recovery) and markedly reduced T(pe) (91 ± 26 milliseconds vs 67 ± 19 milliseconds, P = 0.03 during exercise; 103 ± 26 milliseconds vs 78 ± 11 milliseconds, P = 0.02 during recovery). In contrast, in normal subjects, β-blockade had no effect on QT (320 ± 17 milliseconds vs 317 ± 16 milliseconds, P = 0.29 during exercise; 317 ± 13 milliseconds vs 315 ± 14 milliseconds, P = 0.15 during recovery) and mildly reduced T(pe) (69 ± 13 milliseconds vs 61 ± 11 milliseconds, P = 0.01 during exercise; 77 ± 19 milliseconds vs. 68 ± 14 milliseconds, P < 0.001 during recovery).
Conclusion: In LQT1 patients, β-blockers reduced QT and T(pe) during exercise and recovery, supporting the theory that β-blocker therapy protects LQT1 patients by reducing dispersion of repolarization during exercise and recovery.
© 2011 Wiley Periodicals, Inc.
Figures





Similar articles
-
Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit.Europace. 2014 Dec;16(12):1847-51. doi: 10.1093/europace/euu086. Epub 2014 May 15. Europace. 2014. PMID: 24833771 Clinical Trial.
-
Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.Ann Noninvasive Electrocardiol. 2013 Jul;18(4):399-408. doi: 10.1111/anec.12048. Epub 2013 May 3. Ann Noninvasive Electrocardiol. 2013. PMID: 23879280 Free PMC article.
-
Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.J Am Coll Cardiol. 2002 Jun 19;39(12):1984-91. doi: 10.1016/s0735-1097(02)01894-6. J Am Coll Cardiol. 2002. PMID: 12084597
-
Congenital and acquired long QT syndrome. Current concepts and management.Cardiol Rev. 2004 Jul-Aug;12(4):222-34. doi: 10.1097/01.crd.0000123842.42287.cf. Cardiol Rev. 2004. PMID: 15191637 Review.
-
The inherited long QT syndrome: from ion channel to bedside.Cardiol Rev. 1999 Jan-Feb;7(1):44-55. Cardiol Rev. 1999. PMID: 10348966 Review.
Cited by
-
Long QT syndrome: a Korean single center study.J Korean Med Sci. 2013 Oct;28(10):1454-60. doi: 10.3346/jkms.2013.28.10.1454. Epub 2013 Sep 25. J Korean Med Sci. 2013. PMID: 24133349 Free PMC article.
-
A Systematic Review on the Role of Βeta-Blockers in Reducing Cardiac Arrhythmias in Long QT Syndrome Subtypes 1-3.Cureus. 2021 Sep 1;13(9):e17632. doi: 10.7759/cureus.17632. eCollection 2021 Sep. Cureus. 2021. PMID: 34646680 Free PMC article. Review.
-
Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy.Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):211-9. doi: 10.1007/s00399-012-0232-8. Epub 2012 Sep 21. Herzschrittmacherther Elektrophysiol. 2012. PMID: 22996910
-
Effects of propranolol and exercise training in children with severe burns.J Pediatr. 2013 Apr;162(4):799-803.e1. doi: 10.1016/j.jpeds.2012.09.015. Epub 2012 Oct 17. J Pediatr. 2013. PMID: 23084706 Free PMC article. Clinical Trial.
-
Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.Front Physiol. 2022 Nov 23;13:902224. doi: 10.3389/fphys.2022.902224. eCollection 2022. Front Physiol. 2022. PMID: 36505078 Free PMC article.
References
-
- Swan H, Toivonen L, Viitasalo M. Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. Eur Heart J. 1998;19:508–513. - PubMed
-
- Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol. 1999;34:823–829. - PubMed
-
- Shimizu W, Ohe T, Kurita T, Shimomura K. Differential response of QTU interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. Pacing Clin Electrophysiol. 1991;14:1966–1970. - PubMed
-
- Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;77:413–421. - PubMed
-
- Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol. 2003;41:633–642. - PubMed